Study Reveals Blood Cancer Patients on Bruton Tyrosine Kinase Inhibitors Can Safely Continue Treatment During COVID-19 Vaccination
In a groundbreaking development for patients suffering from blood cancer, recent research led by the University of Birmingham and the ...
